Beth Israel Comprehensive Cancer Center — Boston, Massachusetts

Beth Israel Comprehensive Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Comprehensive Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Multiple Myeloma.

Sponsors: Clovis Oncology, Inc., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Comprehensive Cancer Center?

Beth Israel Comprehensive Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Comprehensive Cancer Center conducted?

Beth Israel Comprehensive Cancer Center has 2 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Multiple Myeloma.

Is Beth Israel Comprehensive Cancer Center accredited by Crixeo Health?

Beth Israel Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.